Jeff Jaeckel

Partner

Washington D.C., 202.778.1440

Download vCard

Education

The College of William & Mary (B.A., 1995)
;
University of Wisconsin Law School (J.D., 1998)

Practices

Antitrust + Competition Law

Litigation

Bar Admissions

District of Columbia

Jeff Jaeckel is head of Morrison & Foerster's Washington, D.C. and Virginia Litigation Department. Mr. Jaeckel is an antitrust expert, litigator, and counselor. He regularly represents foreign and domestic corporations in connection with all manner of antitrust and competition law matters, from M&A investigations to cartel investigations to civil litigation.

Mr. Jaeckel has notable experience representing corporations in connection with their most significant and complicated antitrust litigation, and in guiding corporations through domestic and international government investigations in the merger context or in criminal cartel investigations. Mr. Jaeckel also assists clients in the protection of their intellectual property and counsels clients on the antitrust ramifications of commercial agreements to capitalize on the value of intellectual property.

Mr. Jaeckel serves as an Associate Editor of the Antitrust Magazine of the American Bar Association Antitrust Section, and is a member of the firm's E-Discovery Task Force. He graduated with honors and was a member of Omicron Delta Epsilon, the international honor society in Economics. He was a writing staff member for the Wisconsin Environmental Law Journal, and was elected to Order of the Coif.

Astellas Pharma Inc.

Successfully represented Astellas Pharma Inc. before the Federal Trade Commission in its $4 billion tender offer for OSI Pharmaceuticals Inc., the second largest U.S. acquisition by a Japanese pharmaceutical firm.

Sale of Alltel to Verizon Wireless

Successfully represented Alltel Corporation before the Department of Justice in its $28-billion acquisition by Texas Pacific Group and Goldman Sachs, and in its $28.5-billion acquisition by Verizon Wireless to create the largest wireless operator in the U.S. (2008)

Clearwire/Sprint Nextel

Represented Clearwire Corporation, an innovative wireless communications company developing next-generation wireless broadband technology called WiMAX, before the U.S. Department of Justice in a deal with Sprint Nextel Corporation, Intel Corporation, Google, Inc., Comcast Corporation, Time Warner Cable Inc., and Bright House Networks to create a national WiMAX joint venture valued at approximately $14.5 billion. (2008)

Genentech/Tanox

Represented Tanox Inc. before the Federal Trade Commission in its $919-million acquisition by Genentech. (2007)

Astellas Pharma Inc. $537 million Acquisition

Represented Astellas Pharma Inc., Japan's second-largest drug maker, in its acquisition of Agensys Inc., a leading U.S.-based biotechnology unit developing several novel cancer treatments.

Astellas Pharma Merger

Represented Fujisawa Pharmaceutical Co. and Yamanouchi Pharmaceutical Co. before Federal Trade Commission in connection with their $7 billion merger to form Astellas Pharma Inc., Japan's second largest pharmaceutical company. (2006)

Merger of Sankyo and Daiichi Pharmaceutical

Represented Sankyo Co. and Daiichi Pharmaceutical Co. before the Federal Trade Commission in relation to their multi-billion dollar merger to form Daiichi Sankyo. (2006)

Celltech Ltd.

Represented Celltech Ltd. in intellectual property and antitrust litigation against MedImmune Inc. (2006)

Southwest/AirTran

Represented AirTran Holdings, Inc. before the U.S. Department of Justice in connection with Southwest Airlines Co.’s $1.4 billion acquisition of AirTran. (2011)